Detalhe da pesquisa
1.
Lenvatinib plus Pembrolizumab Combination Therapy for Advanced or Recurrent Endometrial Cancer: A Single-Center, Retrospective Analysis.
Tohoku J Exp Med
; 262(2): 85-95, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008437
2.
Long-Term and Short-Interval Assessment of Self-Reported Urinary and Sexual Functions after Nerve-Sparing Radical Hysterectomy: A Prospective Cohort Study.
Tohoku J Exp Med
; 263(1): 1-9, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325829
3.
Assessing the Significance of Lymphadenectomy in Older Patients with Stage I Endometrial Cancer: A Single-Center, Retrospective Cohort Study.
Tohoku J Exp Med
; 261(1): 83-93, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407439
4.
Ceramide synthase 2-C24:1 -ceramide axis limits the metastatic potential of ovarian cancer cells.
FASEB J
; 35(2): e21287, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423335
5.
A Retrospective Analysis of Clinical Biomarkers for Olaparib Maintenance Therapy in Patients with Recurrent Ovarian Cancer.
Tohoku J Exp Med
; 258(1): 1-9, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705321
6.
MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression.
Tohoku J Exp Med
; 256(3): 249-258, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314531
7.
A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.
Tohoku J Exp Med
; 254(3): 145-153, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34219103
8.
MicroRNA Let-7c Contributes to Paclitaxel Resistance via Aurora-B in Endometrial Serous Carcinoma.
Tohoku J Exp Med
; 251(4): 263-272, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727972
9.
La-Related Protein 4 as a Suppressor for Motility of Ovarian Cancer Cells.
Tohoku J Exp Med
; 247(1): 59-67, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30686809
10.
Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer.
Cancer Sci
; 108(4): 795-803, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28161904
11.
Development of a new clinically applicable device for embryo evaluation which measures embryo oxygen consumption.
Hum Reprod
; 31(10): 2321-30, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609982
12.
Diagnostic Performance of Preoperative Imaging in Endometrial Cancer.
Curr Oncol
; 30(9): 8233-8244, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754512
13.
Precautions during Direct Oral Anticoagulant Introduction in Gynecologic Malignancies: A Single-Center Retrospective Cohort Study.
Cancers (Basel)
; 15(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831475
14.
Involvement of small extracellular vesicle-derived TIE-1 in the chemoresistance of ovarian cancer cells.
Cancer Treat Res Commun
; 27: 100364, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812182
15.
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
PLoS One
; 16(6): e0251079, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161330
16.
Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer.
Cancers (Basel)
; 12(6)2020 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604863
17.
Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers.
Oncotarget
; 9(3): 3483-3496, 2018 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423060
18.
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.
Sci Rep
; 8(1): 13207, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181600
19.
Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer.
Mol Cancer Ther
; 17(1): 50-59, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079707
20.
Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy.
Cancer Res
; 65(11): 4683-9, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15930286